Ingap-peptide variants as a novel therapy for type 1 diabetes: effect on human islet insulin secretion and gene expression

HIGHLIGHTS

• who: James M. Porter and collaborators from the Department of Biological and Biomedical Engineering, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H A , Canada have published the paper: INGAP-Peptide Variants as a Novel Therapy for Type 1 Diabetes: Effect on Human Islet Insulin Secretion and Gene Expression, in the Journal: Pharmaceutics 2022, 14, x FOR PEER REVIEW of /2022/
• what: Since INGAP-P has been shown to increase islet proliferation after 24 h, the authors focused on the insulin stimulatory and gene regulation properties of the peptide, which has shown to . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.